Cyrille Leperlier
Director/Board Member at NUCANA PLC
Net worth: - $ as of 2024-03-30
Profile
Cyrille Raymond George Leperlier is currently the Chief Executive Officer at Divlal SAS since 2020 and an Independent Non-Executive Director at NuCana Plc since 2018.
Previously, he worked as a Medical Director at Rhone-Poulenc Rorer, Inc. and Sanofi-Aventis Japan from 2004 to 2019, where he held the position of Medical Director from 2014 to 2019.
He obtained a graduate and doctorate degree from the University of Paris Jussieu.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NUCANA PLC
-.--% | 2023-12-30 | 0 ( -.--% ) | - $ | 2024-03-30 |
Cyrille Leperlier active positions
| Companies | Position | Start |
|---|---|---|
| NUCANA PLC | Director/Board Member | 2018-04-30 |
| Divlal SAS | Chief Executive Officer | 2020-05-31 |
Former positions of Cyrille Leperlier
| Companies | Position | End |
|---|---|---|
| Sanofi-Aventis Japan | Chief Tech/Sci/R&D Officer | 2019-11-30 |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Chief Tech/Sci/R&D Officer | - |
Training of Cyrille Leperlier
| University of Paris Jussieu | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NUCANA PLC | Health Technology |
| Private companies | 3 |
|---|---|
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
| Sanofi-Aventis Japan | |
| Divlal SAS |
- Stock Market
- Insiders
- Cyrille Leperlier
